1. Home
  2. TDF vs EMBC Comparison

TDF vs EMBC Comparison

Compare TDF & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Templeton Dragon Fund Inc.

TDF

Templeton Dragon Fund Inc.

N/A

Current Price

$10.21

Market Cap

268.9M

Sector

Finance

ML Signal

N/A

Logo Embecta Corp.

EMBC

Embecta Corp.

N/A

Current Price

$5.25

Market Cap

279.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TDF
EMBC
Founded
1994
1924
Country
Singapore
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
268.9M
279.9M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
TDF
EMBC
Price
$10.21
$5.25
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$18.50
AVG Volume (30 Days)
39.3K
1.2M
Earning Date
01-01-0001
05-05-2026
Dividend Yield
N/A
6.88%
EPS Growth
N/A
20.90
EPS
N/A
1.03
Revenue
N/A
N/A
Revenue This Year
N/A
$1.17
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$4.94
Revenue Growth
N/A
N/A
52 Week Low
$10.26
$2.77
52 Week High
$12.20
$15.55

Technical Indicators

Market Signals
Indicator
TDF
EMBC
Relative Strength Index (RSI) 30.55 52.77
Support Level N/A $4.80
Resistance Level $11.14 $5.77
Average True Range (ATR) 0.19 0.27
MACD -0.05 -0.09
Stochastic Oscillator 7.79 26.13

Price Performance

Historical Comparison
TDF
EMBC

About TDF Templeton Dragon Fund Inc.

Templeton Dragon Fund Inc is a closed-end management investment company. The fund seeks long-term capital appreciation by investing majority of its total assets in equity securities of China companies. It invest in various sectors such as gas & consumable fuels, auto components, banks, beverages, communications equipment, healthcare equipment & supplies, restaurants & leisure, household durables and many others.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: